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Insulin-induced serine 22 phosphorylation of retinoid X receptor alpha is
dispensable for adipogenesis in brown adipocytes
Jacob Ardenkjær-Larsen , Kaja Rupar, Goda Sinkevičiūtė, Patricia S. S. Petersen , Julia Villarroel ,
Morten Lundh, Romain Barrès, Atefeh Rabiee, and Brice Emanuelli
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen,
Copenhagen, Denmark
ABSTRACT
Insulin action initiates a series of phosphorylation events regulating cellular differentiation, growth and
metabolism. We have previously discovered, in a mass spectrometry-based phosphoproteomic study,
that insulin/IGF-1 signalling induces phosphorylation of retinoid x receptor alpha (RXRα) at S22 inmouse
brown pre-adipocytes. Here, we show that insulin induces the phosphorylation of RXRα at S22 in both
brown precursor andmature adipocytes through a pathway involving ERK, downstreamof IRS-1 and−2.
We also found that RXRα S22 phosphorylation is promoted by insulin and upon re-feeding in brown
adipose tissue in vivo, and that insulin-stimulated S22 phosphorylation of RXRα is dampened by diet-
induced obesity. We used Rxra knockout cells re-expressing wild type (WT) or S22A non-
phosphorylatable forms of RXRα to further characterize the role of S22 in brown adipocytes. Knockout
of Rxra in brown pre-adipocytes resulted in decreased lipid accumulation and adipogenic gene expres-
sion during differentiation, and re-expression of RxraWT alleviated these effects. However, we observed
no significant difference in cells re-expressing the RxraS22A mutant as compared with the cells re-
expressing RxraWT. Furthermore, comparison of gene expression during adipogenesis in the WT and
S22A re-expressing cells by RNA sequencing revealed similar transcriptomic profiles. Thus, our data
propose a dispensable role for RXRα S22 phosphorylation in adipogenesis and transcription in differ-
entiating brown pre-adipocytes.
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Introduction
Insulin action in adipose tissue is one of the most
potent signals regulating cell metabolism and differen-
tiation [1]. Insulin resistance, defined at the molecular
level by defective signalling in response to insulin, plays
an important role in metabolic disorders such as obe-
sity and type II diabetes [2]. The elucidation of the
molecular mechanisms mediating insulin signalling is
therefore essential for the development of therapeutic
strategies to treat metabolic disorders.
Activation of insulin and insulin-like growth factor 1
(IGF-1) receptors (IR/IGF-1 R) by their ligands initiates
a cascade of phosphorylation events controlling cellular
differentiation, growth and metabolism [3]. To obtain
a better understanding of the molecular mechanisms
mediating insulin/IGF-1 action, we previously per-
formed a mass spectrometry-based phosphoproteomic
study using brown pre-adipocytes. In this study, we
found retinoid x receptor alpha (RXRα) to be phos-
phorylated on serine 22 (S22) with a 2.9-fold induction
upon IGF-1 stimulation [4]. The RXRα S22 phosphor-
ylation site is located in an autonomous, ligand-
independent transcriptional activation domain in the
N-terminal A/B region of RXRα [5]. This domain is
called ‘activation function 1’ (AF-1) and is required for
the transduction of retinoic acid signals during devel-
opment [6]. It has been reported that RXRα constitu-
tive (without ligand) phosphorylation on S22 is
required for the anti-proliferative effect of retinoic
acid and induction of several retinoic acid-responsive
genes [7]. Phosphorylation at this site is the most
commonly detected post-translational modification of
RXRα in high-throughput studies in mouse, human
and rat [8]. Among these studies, one study found
increased RXRα S22 phosphorylation in human neuro-
blastoma, which had significantly elevated insulin
receptor signalling[9], and another study detected
RXRα S22 phosphorylation in response to insulin in
mature 3T3-L1 adipocytes [10]. However, the physio-
logical relevance and impact of this phosphorylation
event in adipocytes have not been investigated.
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RXRα is a ligand-activated transcription factor that
belongs to the superfamily of nuclear hormone receptors.
It is expressed in many tissues, such as adipose tissue,
liver, kidney, spleen and muscle [11], and plays a role in
development as well as in regulating the physiological
functions of differentiated adult tissues [12]. Several
nuclear receptors heterodimerize with RXRα which
gives it a unique modulatory role across multiple signal-
ling pathways [13]. Genome-wide profiling of peroxisome
proliferator-activated receptor-gamma (PPARγ) and
RXRα binding in 3T3-L1 adipocytes has demonstrated
that the PPARγ:RXRα heterodimer binds to hundreds of
genomic locations in differentiating and mature adipo-
cytes [14], suggesting a role for this heterodimer in adi-
pogenesis and adipocyte metabolism. Consistently,
selective ablation of RXRα in adipose tissue results in
impaired lipolysis during fasting, impaired adipogenesis
and resistance to obesity [15].
Here, we show that the phosphorylation of RXRα at
S22 is promoted by insulin in brown precursor and
mature adipocytes, and in brown adipose tissue (BAT)
in vivo following insulin injection or re-feeding.
Interestingly, insulin-induced RXRα S22 phosphoryla-
tion is dampened by diet-induced obesity. However,
our in vitro studies indicate that RXRα S22 phosphor-
ylation is dispensable for adipogenesis and does not
influence gene expression throughout differentiation.
Results
Insulin triggers phosphorylation of RXRα at S22 in
brown pre-adipocytes and brown adipose tissue
To test whether RXRα phosphorylation on S22,
detected in our phosphoproteomic study, occurs in
response to insulin, we applied an antibody directed
against phosphorylated-S22 RXRα (pRXRα) for protein
analysis using protein lysates from brown pre-
adipocytes stimulated with insulin or vehicle. Three
main bands in the molecular weight range of RXRα
were detected in wild type (WT) cells using the phos-
phospecific antibody, with the middle one correspond-
ing to the expected molecular weight of RXRα (Figure 1
(a)). Notably, the intensity of the two bands of higher
molecular weight was dramatically reduced when
immunoblotting with either pRXRα or total RXRα anti-
body in Rxra−/- cells (Figure 1(a)), or following siRNA-
mediated knockdown of Rxra in brown pre-adipocytes
(Supplementary Figure 1(a)). Furthermore, the same
two bands were detected following RXRα immunopre-
cipitation in WT cells, but not in Rxra−/- cells, by
immunoblotting with either pRXRα or total RXRα anti-
body (Figure 1(a)). Additionally, we confirmed the
specificity of the phosphospecific antibody towards
the phosphorylated form of the RXRα S22 motif using
a peptide competition assay with the phosphorylated
peptide used to generate the pRXRα antibody and its
non-phosphorylated analog (Supplementary Figure 1
(b)). Collectively, these data indicate that two bands
correspond to RXRα, and, importantly, that RXRα S22
phosphorylation is increased upon insulin stimulation
(Figure 1(a); Supplementary Figure 1(a, b)).
Next, we sought to determine if RXRα is phosphory-
lated on S22 in vivo. BAT was taken from mice after
injection with saline or insulin, and protein lysates were
analysed by immunoblotting following immunopreci-
pitation. Interestingly, we observed increased RXRα
phosphorylation on S22 in response to insulin, here at
the level of the higher molecular weight (Figure 1(b)).
Similarly, we observed increased S22 phosphorylation
of RXRα in BAT upon 2 or 6 h of refeeding, high-
lighting that RXRα is phosphorylated on S22 under
normal physiological conditions (Figure 1(c)).
Increased phosphorylation of IR, AKT and ERK in
response to feeding suggests a response to endogenous
insulin (Supplementary Figure 1(c)). Furthermore, to
assess the effect of obesity-associated insulin resistance
on RXRα S22 phosphorylation in BAT, we measured
RXRα S22 phosphorylation in BAT from either lean
mice fed with control diet (CD) or diet-induced obese
and hyperglycaemic mice fed a high-fat diet (HFD) for
8 weeks (Supplementary Figure 1(d)). In BAT, RXRα
S22 phosphorylation in response to insulin was blunted
in HFD-fed animals, as compared to CD-fed mice
(Figure 1(d)). This was paralleled with lower AKT and
ERK activation in the HFD-fed mice, indicative of
insulin resistance in this tissue (Supplementary Figure
1(e)). Thus, RXRα S22 phosphorylation occurs in
response to insulin and refeeding in BAT, and is com-
promised in conditions of insulin resistance.
Insulin triggers S22 phosphorylation of RXRα via
ERK activation in precursor and mature adipocytes
In order to investigate the signalling events mediating
RXRα phosphorylation at S22 in response to insulin, we
assessed RXRα S22 phosphorylation in brown pre-
adipocytes depleted of IRS-1 and −2, the main sub-
strates downstream of IR/IGF-1 R. We found that
insulin- and IGF-1-induced RXRα S22 phosphorylation
was abolished in Irs1−/- and Irs2−/- cells, as compared to
WT brown pre-adipocytes, and this was accompanied
by reduced phosphorylation of AKT and ERK (Figure 2
(a); Supplementary Figure 2(a, b)). These results indi-
cate that IRS-1 and IRS-2 are both required for
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maximal RXRα S22 phosphorylation, and suggest that
AKT or ERK mediate this effect.
To investigate the potential contribution of these two
major insulin-activated pathways in mediating phos-
phorylation of RXRα at S22, pharmacological inhibition
was used to suppress the kinase activities of AKT and
ERK using MK-2206 and U0126, respectively, without
affecting IR activity (Supplementary Figure 2(c)). ERK
inhibition in brown pre-adipocytes prevented insulin-
mediated RXRα S22 phosphorylation (Figure 2(b)). In
contrast, there was enhanced insulin-mediated ERK and
RXRα S22 phosphorylation upon AKT inhibition (Figure
2(b); Supplementary Figure 2(c)). Thus, ERK is the main
kinase involved in mediating insulin-induced RXRα S22
phosphorylation in brown pre-adipocytes.
To study how phosphorylation of RXRα on S22 is
regulated throughout adipogenesis, brown pre-
adipocytes were induced to differentiate and were stimu-
lated with insulin or vehicle across differentiation at four
time points (day 0, 2, 4 or 6). Increased maturation of
the brown pre-adipocytes was indicated by increases in
IR, FAS and GAPDH abundance (Figure 2(c)) [16].
RXRα S22 phosphorylation occurred in response to
insulin at all time points except for day 2 (Figure 2(c)),
and this was paralleled by a similar phosphorylation
pattern of ERK (Supplementary Figure 2(d)). These
results indicate that insulin mediates S22 phosphoryla-
tion of RXRα in both brown precursor and mature
adipocytes, and suggests that RXRα S22 phosphorylation
may play an important role during adipogenesis, and to
modulate adipocyte functions.
RXRα S22 phosphorylation is dispensable for
adipogenesis
To assess the role of RXRα S22 phosphorylation in
mediating insulin action, we generated cells in which
phosphorylation of RXRα on S22 was prevented. This
was accomplished by reconstituting Rxra−/- brown pre-
adipocytes with WT or S22A mouse Rxra (Figure 3(a)).
Figure 1. Insulin stimulates phosphorylation of RXRα at S22 in vitro and in vivo. Representative immunoblots with quantified pRXRα
(56 kDa and 65 kDa, separately) and RXRα (56 kDa and 65 kDa together) band intensities in brown pre-adipocytes and mouse BAT
presented as mean ± SE. Immunoprecipitation (IP) was performed using control IgG or RXRα antibody (D6H10). A different RXRα
antibody (D-20) was used for immunoblotting. Lysate input or immunoprecipitated RXRα were prepared from (a) WT or Rxra−/-
brown pre-adipocytes treated with insulin or vehicle; n = 3; or (b) BAT from mice injected with insulin or saline; n = 5; two-tailed
t-test or two-way ANOVA with Šídák’s multiple comparison tests. (c) BAT from mice that were fasted or refed for 2 or 6 h; n = 6; one-
way ANOVA and Dunnett’s multiple comparison test. (d) BAT from mice that were fed with CD or HFD and were injected with insulin
or saline; n = 5–6; two-way ANOVA and Šídák’s multiple comparison test. All phosphoprotein band intensities are normalized to the
total amount of each respective protein, except in immunoprecipitation experiments where pRXRα and RXRα are quantified
separately. Asterisk (*) represents a significant difference (p < 0.05) from vehicle-treated control cells, fasted mice or saline-
injected control mice. Hash (#) represents a significant difference (p < 0.05) from WT cells, BAT RXRα IP or insulin-injected CD mice.
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While insulin induced S22 phosphorylation of RXRα in
two separate Rxra−/- clones re-expressing RxraWT
(Supplementary Figure 3(a)), there was no detectable
S22 phosphorylation of RXRα in Rxra−/- cells re-
expressing RxraSA in response to insulin
(Supplementary Figure 3(b)) or adipogenic induction
(Figure 3(b); Supplementary Figure 3(c)), despite com-
parable abundance of RXRα protein. Given the adipo-
genic action of insulin and the role of RXRα in
adipogenesis through dimerization with the master reg-
ulator PPARγ, we next compared the ability of these
brown pre-adipocyte cell lines to differentiate. The adi-
pogenic potential of each cell line was assessed by
comparing expression of different markers of differen-
tiation, such as protein levels of FAS, IR, GLUT4 and
GAPDH (Figure 3(b)) and expression of Fasn, Fabp4,
Slc2a4, Pparg2, Adipoq, Cebpa, G0s2 and Ndufb3
mRNA (Figure 3(c)). As expected, these classic
adipogenic markers were more abundant (p < 0.05;
overall effect of days using two-way ANOVA) in fully
differentiated adipocytes (day 6) than at the pre-
adipocyte stage (day 0). At day 6, there was a lower
expression of adipogenic markers in the Rxra−/- cells
compared with WT controls, indicative of a defect in
adipogenesis. Upon re-introduction of RxraWT in
Rxra−/- cells, the expression of these markers increased
to reach levels close to those of WT cells, indicating
that exogenously delivered RXRα was able to restore
the adipogenic capacity of Rxra−/- cells. Remarkably, re-
expression of RxraSA resulted in restored expression of
adipogenic genes to a similar level as in cells re-
expressing RxraWT. Consistent with this, lipid staining
of differentiated brown adipocytes at day 6 was lower in
Rxra−/- cells and partially rescued in cells re-expressing
RxraWT, with equal lipid accumulation in RxraWT
and RxraSA (Figure 3(d)). Collectively, these data
Figure 2. Insulin stimulates S22 phosphorylation of RXRα via ERK in precursor and mature adipocytes. Representative immunoblots
with quantified pRXRα band intensities presented as mean ± SE; n = 3; two-way ANOVA with Šídák’s and Dunnett’s multiple
comparison tests. (a) WT, Irs1−/- or Irs2−/- brown pre-adipocytes were treated with insulin or vehicle. (b) Brown pre-adipocytes were
pre-treated with vehicle (DMSO), AKT inhibitor (MK-2206) or MEK inhibitor (U0126), and then stimulated with insulin or vehicle. (c)
Brown pre-adipocytes at day 0, 2, 4 or 6 of differentiation were stimulated with insulin or vehicle. All phosphoprotein band
intensities are normalized to the total amount of each respective protein. Asterisk (*) represents a significant difference (p < 0.05)
from vehicle-treated control cells. Hash (#) represents a significant difference (p < 0.05) from WT cells, DMSO-treated cells or D0 cells.
ADIPOCYTE 145
indicate that RXRα WT and SA are equally capable of
rescuing adipogenesis in Rxra−/- cells.
RXRα S22 phosphorylation does not affect gene
expression during adipogenesis
We then hypothesized that RXRα S22 phosphorylation
may play a role in the transcriptional control of differen-
tiating adipocytes. Two different Rxra−/- clones, each re-
expressing RxraWT or RxraSA, were induced to differ-
entiate, and high-throughput RNA sequencing was per-
formed to compare the transcriptomic profiles at 0, 2 or
6 days following induction of differentiation.
Multidimensional scaling (MDS) revealed a clear separa-
tion between the three time points (Figure 4(a)).
Strikingly, the transcriptomes of the cells re-expressing
either RxraWT or RxraSA were indistinguishable at
each day of the differentiation process. Furthermore,
Figure 3. Adipocyte maturation occurs independently of RXRα phosphorylation at S22. (a) WT brown pre-adipocytes were
transfected with EV, and Rxra−/- cells were transfected with EV, RxraWT or RxraSA. (b) Immunoblots with quantified band intensities
at day 0 or day 6 of differentiation; n = 4; two-way ANOVA and Tukey’s multiple comparison test. All protein band intensities are
normalized to vinculin, except for pRXRα and RXRα, which are quantified separately. (c) Gene expression analysis by RT-qPCR
showing mRNA levels of adipogenic markers at day 0 or day 6 of differentiation; n = 4; two-way ANOVA and Tukey’s multiple
comparison test. (d) Lipid staining with Oil Red O at day 6 of differentiation; n = 3; one-way ANOVA and Tukey’s multiple comparison
test. The presented values are mean ± SE. Asterisk (*) represents a significant difference (p < 0.05) from sample indicated with the
scarab (¤) sign. Other comparisons are indicated with a hash (#) representing statistical significance (p < 0.05) and n.s. as an
abbreviation for non-significance (p > 0.05).
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there was no significant statistical difference in RNA
levels of any genes between the cells re-expressing
RxraWT or RxraSA, with transcript counts approxi-
mately equal for every gene in the two cell populations
at all three time points (Figure 4(b)). Performing the data
analysis for each Rxra−/- clone separately did not further
reveal any significant difference at any time point. There
was little overlap between the two Rxra−/- clones for the
genes approaching significance for differential expression,
illustrating that they are unlikely to be caused by S22A
mutation (Supplementary Figure 4(a, b)). Collectively,
our data indicate that RXRα S22 phosphorylation does
not impact transcriptional regulation in brown adipocytes
during adipogenesis in vitro.
Discussion
Brown adipocytes are important for the regulation of
metabolic homoeostasis, and further insight into the
signalling events controlling thermogenic adipocyte dif-
ferentiation and function is essential for understanding
and treating metabolic disorders. During adipogenesis,
external adipogenic signals activate a cascade of tran-
scription factors that are critical for differentiation.
These transcription factors include the two nuclear
hormone receptors PPARγ and RXRα that heterodi-
merize and regulate transcription of various genes
involved in adipogenesis, as well as lipid and glucose
metabolism [17]. Our study sought to uncover a role of
insulin-stimulated RXRα phosphorylation at S22 in
brown adipocytes.
Using a newly generated antibody specifically raised
against the phosphorylated form of RXRα, we show that
RXRα phosphorylation on S22 occurs in brown precursor
and mature adipocytes in response to insulin or IGF-1.
This is consistent with phosphoproteomic studies that
detected the S22 phosphorylation in WT-1 brown pre-
adipocytes in response to IGF-1 [4], and in mature 3T3-
L1 adipocytes in response to insulin [10]. In the present
study, we additionally show that S22 phosphorylation of
RXRα occurs in BAT, indicating its physiological rele-
vance. Moreover, our data indicate that this phosphoryla-
tion is dysregulated with insulin resistance, revealing
a potential role in pathophysiological situations.
Interestingly, insulin-induced RXRα S22 phosphorylation
in vivo was detected by immunoblotting as a band of
higher molecular weight than in cultured cells. It was
previously reported that hyperphosphorylation of RXRα
at four residues (distinct from S22) causes an upward
shift in electrophoretic mobility [18], which is character-
istic of proline-directed sites such as these four phosphor-
ylation sites. This suggests that insulin induces RXRα
phosphorylation on S22 in a non-hyperphosphorylated
state in vitro, while S22 phosphorylation in vivo occurs in
conjunction with hyperphosphorylation. Our pharmaco-
logical inhibition results indicate that ERK is necessary
for insulin-induced phosphorylation of RXRα at S22. As
this site matches the consensus sequence for proline-
directed kinases such as mitogen-activated protein
kinases (MAPKs), this further suggests that ERK itself
may catalyse the S22 phosphorylation reaction.
Interestingly, a missense single nucleotide polymorphism
(SNP) in the RXRA gene (rs55836231) [19] is predicted to
cause a loss-of-phosphorylation at S21 (the correspond-
ing phosphorylation site in humans) [20] by disrupting
the phosphorylation motif.
As both insulin action and ERK activation promote
adipogenesis [21], insulin-stimulated S22 phosphorylation
of RXRα by ERK is suggestive of a role for RXRα S22
phosphorylation in adipocyte differentiation.
Furthermore, RXRα is the heterodimerization partner of
PPARγ in adipose cells, constituting a master transcrip-
tional complex coordinating adipocyte differentiation.
Figure 4. RXRα phosphorylation at S22 is not involved in the regulation of gene expression during brown adipocyte differentiation.
Two different Rxra−/- brown pre-adipocyte clones re-expressing RxraWT or RxraSA were differentiated to day 0, 2 or 6, followed by
high-throughput RNA sequencing; n = 3 for each cell line. (a) Similarities in gene expression profiles between the four different lines,
and across differentiation, are visualized using MDS. (b) Scatter plots illustrating transcript counts per million (CPM) at each time
point.
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Confirming a role for RXRα in brown adipocyte differen-
tiation, our newly generated Rxra−/- cells exhibit impaired
differentiation compared with WT cells. This is consistent
with a previous study reporting that adipocyte-specific
knockout of Rxra results in poor adipocyte differentia-
tion [15]. Re-introduction of WT RXRα into Rxra−/- cells
largely restored adipogenesis. However, re-expressing Rxra
with an S22Amutation resulted in similar lipid content and
gene expression pattern as when re-expressing RxraWT.
This indicates that RXRα S22 phosphorylation is dispen-
sable for the differentiation of brown pre-adipocytes into
mature adipocytes and does not influence gene expression
during adipogenesis. PPARγ itself is phosphorylated by
MAPKs in the AF-1 transactivation domain in 3T3-L1
cells which reduces ligand-dependent transcriptional activ-
ity [22] and inhibits adipogenic activity [23]. Conversely,
our data indicate that RXRα S22 phosphorylation in the
AF-1 domain does not affect RXRα:PPARγ heterodimer
function in adipocyte transcriptional control. In Ras-
transformed keratinocytes, phosphorylation of human
RXRα at S260 affects its cellular localization and its binding
to chromatin and to the vitamin D receptor (VDR) [24].
Like S22, phosphorylation at this site occurs via
MAPK [25]. This raises the possibility that S22 phosphor-
ylation may play a role in modulating RXRα function by
altering, e.g, localization or partnering of RXRα, or its
transcriptional activity. Phosphorylation of RXRα at
S22 has previously been shown to affect the expression of
retinoic acid-responsive genes in F9 embryocarcinoma
cells [7]. This role for RXRα S22 phosphorylation in tran-
scriptional regulation was observed in response to retinoic
acid, suggesting that RXRα S22 phosphorylationmodulates
RXRα activity only in the presence of its ligand.
Alternatively, because RXRα is phosphorylated onmultiple
sites, it is possible that a potential outcome of S22 phos-
phorylation in regulating RXRα function might require
phosphorylation on other residues. Our results revealed
that insulin-mediated phosphorylation of S22 in BAT is
associated with hyperphosphorylation, which could indi-
cate that S22 phosphorylation operates differently in vivo,
where it may potentially interact with other phosphoryla-
tion events. In addition, the dampening of insulin-induced
S22 phosphorylation observed in BAT fromHFD-fed mice
could indicate a potential role in the pathogenesis of insulin
resistance. Similarly, dysregulation of gene expression
upon phosphorylation of PPARγ on S273 by cyclin-
dependent kinase 5 (CDK5) is particularly apparent in
the context of obesity [26].
In conclusion, our findings reveal that RXRα is
phosphorylated on S22 in BAT and in cultured brown
adipocytes in response to insulin. We show that S22
phosphorylation is dispensable for the regulation of
transcription during adipogenesis in brown adipocytes.
Yet, whether RXRα S22 phosphorylation affects RXRα
function and the regulation of metabolic processes
in vivo remains to be determined, in particular in
obese conditions.
Materials and methods
Animal housing and diet
All mice were housed at 22°C under daily 12 h light/
dark cycles. Ten 9–11-week-old male C57BL/6 J mice
were fasted for 4 h and anaesthetized, followed by
retro-orbital injection of 1 unit insulin/saline for
5 min (5 mice per group). For the fasting/refeeding
challenge, 9-week old male mice were fasted over-
night, refed for either 2 or 6 h (6 mice per group),
and euthanized [27]. For the high-fat diet challenge,
6-week old male mice were fed with either control
diet (D12450B, Research Diets, Inc., USA) or high-fat
diet (D12492, Research Diets, Inc., USA) for 8 weeks.
The mice were fasted for 2 h, prior to injection with
insulin/saline (5–6 mice per group), and euthanized.
Tissues were collected right after euthanasia and
immediately snap frozen in liquid nitrogen. All ani-
mal experiments were approved by the Danish autho-
rities (permit number 2015-15-0201-00728) at the
University of Copenhagen.
Cell culture
Wild-type (WT), Irs1−/- and Irs2−/- brown preadipocyte
cell lines were a kind gift from C. Ronald Kahn [28].
Cells were cultured in Dulbecco’s modified Eagle’s
medium (DMEM) containing 10% foetal bovine
serum and 1% penicillin-streptomycin (PS), in humidi-
fied incubators at 37°C and 5% CO2. For differentia-
tion, pre-adipocytes were grown to confluence (day 0)
in culture medium supplemented with 20 nM insulin
and 1 nM triiodothyronine (differentiation medium).
Confluent cells were incubated for 2 d in differentiation
medium further supplemented with 1 μM dexametha-
sone, 0.5 mM isobutylmethylxanthine and 0.125 mM
indomethacin. Subsequently, the cells were maintained
in differentiation medium. Culture medium was chan-
ged every 2 d, and cell culturing experiments were
performed in independent replicates.
For stimulation experiments, cells were starved for 4 h in
DMEMwith 1% PS and 0.1% bovine serum albumin. Cells
were stimulated with 100 nM insulin or IGF-1, or vehicle
for 5 min before lysis. For kinase inhibition, cells were pre-
treated with 10 μM U0126-EtOH (Selleck Chemicals),
10 μM MK-2206 (Active Biochem) or vehicle (0.1%
DMSO) for 1 h before stimulation.
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Transient knockdown
Knockdown of Rxra was performed by RNA interfer-
ence in brown pre-adipocytes. At 80% confluency, the
cells were transfected with a pool of four siRNAs tar-
geting Rxra (LQ-050277-01-0002, Dharmacon) or
a pool of four non-targeting control (NTC) siRNAs
(D-001810-10-05, Dharmacon) using Lipofectamine
RNAiMAX Transfection Reagent (Thermo Fisher) and
Opti-MEM Reduced Serum Medium (Thermo Fisher)
according to the manufacturer’s instructions. Cells were
incubated for 2 d before lysis and subsequent protein
analysis.
Targeted genome editing
The CRISPR/Cas9 system was used for knocking out
the Rxra gene in a clonal cell line derived from WT
pre-adipocytes. Single guide RNAs (sgRNAs) were
designed using the CRISPR Design Tool (https://
zlab.bio/guide-design-resources) and delivered via
a sgRNA-expressing plasmid. The targeting sequence
(5ʹ-GCCATGGAGCCTCGACCCGT-3ʹ) of the sgRNA
was ligated into a pSpCas9(BB)-2A-GFP (PX458) vec-
tor [29], which was replicated using chemically com-
petent E. coli. Correct insertion was verified by Sanger
sequencing. The Nucleofector 2b Device (Lonza) was
used to deliver the plasmids into the WT cell clone by
electroporation using Cell Line Nucleofector Kit
R (Lonza Group). After 2 d, the cells were separated
based on green fluorescent protein (GFP) intensity
using fluorescence-activated cell sorting. Monoclonal
cell populations were obtained from the GFP-positive
cells by isolation of single cells via dilution, and
frameshift mutations were confirmed by Sanger
sequencing. Two independent Rxra−/- clones were
subsequently used for experiments.
Subcloning and mutagenesis
Mouse Rxra cDNA, reverse transcribed from brown pre-
adipocyte mRNA, was cloned into overhanging 3ʹ deox-
ythymidine residues of pCR2.1-TOPO (Invitrogen) after
PCR amplification with specific primers carrying appro-
priate restriction sites at their 5′ ends. The full-length
cDNAwas validated by Sanger sequencing and subcloned
into EcoRI and SalI sites of pBabe Hygro (#1765,
Addgene) [30], a retroviral expression plasmid, generat-
ing pBabe Hygro Mouse Rxra. A missense mutation was
introduced in the plasmid using the Q5 Site-Directed
Mutagenesis Kit (New England Biolabs) to generate
a plasmid coding for RXRα with a serine-to-alanine sub-
stitution at residue 22.
Retroviral transduction
Homozygous Rxra knockout cells were transduced with
empty vector (EV) or retroviral vector containing WT
or S22A mutant Rxra. A CRISPR/Cas9-targeted cell
clone without Rxra frameshift indels was transduced
with EV and was used as control.
HEK293 FT cells were transiently transfected with
pBabe Hygro Mouse Rxra, pUMVC (#8449,
Addgene) [31] and pCAG-Eco (#35617, Addgene) in
the ratio of 8:8:1 using the TransIT-X2 Dynamic
Delivery System. After incubation for 3 d, virus-
containing medium was transferred to brown pre-
adipocytes together with 8 μg/mL polybrene. Antibiotic
selection with hygromycin (200 μg/mL) started 3 d after
virus infection and until all uninfected control cells were
eliminated.
Protein immunoblotting
Cells were washed with cold phosphate-buffered saline
(PBS) and lysed in RIPA buffer containing protease and
phosphatase inhibitors. Lysate was collected and cen-
trifuged for 10 min at 4°C and 16,100 rcf to pellet
insoluble material. The pellet was discarded, and pro-
tein concentrations of cell lysates were determined with
bicinchoninic acid assay. The samples were diluted to
equal protein concentrations and mixed with Laemmli
sample buffer. Proteins were separated by SDS-PAGE
and transferred onto a PVDF membrane.
Immunostaining was performed using the primary
antibodies shown in Supplementary Table 1 and HRP-
conjugated secondary antibodies (Bio-Rad). A rabbit
polyclonal antibody specific to phosphoserine 22 in
RXRα was produced by Thermo Fisher Scientific with
a synthetic phosphopeptide corresponding to residues
18–28 of mouse RXRα ([C]-SSLNS(p)PTGRGS-amide).
In the peptide competition assay, the phospho-RXRα
(pRXRα) antibody was pre-incubated for 1 h at room
temperature with either water, the immunizing phos-
phopeptide that the antibody was raised against, or the
non-phosphorylated analog peptide. The samples were
electrotransferred together in three copies which were
cut apart and immunostained in parallel with the anti-
body solutions. The membrane pieces were assembled
for chemiluminescent detection.
Immunoprecipitation
Brown pre-adipocytes were lysed according to the
immunoblotting procedure, and samples were diluted
to equal protein concentrations. Samples were then
incubated with RXRα (D6H10) antibody (#3085, Cell
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Signalling Technology) or normal rabbit IgG (#2729,
Cell Signalling Technology) overnight at 4°C while
rotating. Immunocomplexes were captured by incuba-
tion with Protein A Sepharose beads for another 4
h. The beads were washed 3 times in TBST and eluted
using Laemmli buffer. For tissue samples, the beads
were washed in lysis buffer instead. Immunoblotting
was performed using a secondary antibody (ab99697,
Abcam) specific to the light chain of rabbit IgG to
avoid co-detection of IgG heavy chain from the pri-
mary antibody.
Gene expression analysis
RNA from cultured cells was extracted using RNeasy
Kit (Qiagen), and cDNA was synthesized using iScript
cDNA Synthesis Kit (Bio-Rad) according to the manu-
facturer’s instructions. Real-time quantitative PCR was
performed using Brilliant III Ultra-Fast SYBR Green
QPCR Master Mix (Agilent) and the CFX384 Real-
Time PCR Detection System (Bio-Rad) according to
the supplier’s manual. Each cDNA sample was run in
technical triplicates, and the 2−ΔΔCt method was used
for relative quantification with normalization to the
sum of Rn18 s and Tbp. Primer sequences are shown
in Supplementary Table 2.
Lipid staining
Differentiated cells were washed twice in PBS followed
by fixation in 10% formaldehyde for 30 min. Fixed cells
were washed twice in distilled water and then equili-
brated with 60% isopropanol in water for 5 min. Lipids
were stained by incubating cells for 20 min with
a freshly prepared solution of 0.3% Oil Red O and
60% isopropanol in water. Finally, the cells were
washed in distilled water to remove excess stain and
were covered with water when viewed under the
microscope.
For relative quantification, the cells were washed
twice for 5 min in 60% isopropanol while agitating.
Oil Red O stain was extracted with 100% isopropanol
for 20 min while agitating. Absorbance was read at
518 nm, and the absorbance of 100% isopropanol was
subtracted (background).
RNA sequencing
Cell lysis and phase separation were performed using
TRIzol Reagent (Invitrogen) according to the manufac-
turer’s instructions. The upper part of the aqueous phase
was transferred to a new tube and mixed with an equal
volume of 70% RNase-free ethanol. The RNA was purified
using RNeasy Kit (Qiagen), including the DNase digestion
step, according to the manufacturer’s instructions. RNA
quantity and quality were assessed using NanoDrop 2000
(Thermo Scientific) and RNA 6000 Nano Kit (Agilent),
respectively. Library preparation was performed using
TruSeq Stranded Total RNA Library Prep Gold
(Illumina) with RNAClean XP Kit (Agencourt) for RNA
purification, AMPure XP Kit (Agencourt) for DNA pur-
ification and SuperScript III Reverse Transcriptase
(Invitrogen) for cDNA synthesis. DNA quantity and qual-
ity were assessed using Qubit dsDNA HS Assay Kit
(Invitrogen) and High Sensitivity DNA Kit (Agilent),
respectively. High-throughput sequencing was performed
using the NextSeq 500 Sequencing System (Illumina) and
the NextSeq 500/550 High Output Kit v2 (75 cycles).
Transcriptomic analysis
Paired-end reads were checked for quality with FastQC and
aligned to the CRCm38.p6 GENCODE primary assembly,
version M21 using STAR v2.7.0d [32]. Read summation
onto genes of the comprehensive gene annotation on the
aforementioned primary assembly was performed by
featureCounts v1.6.2 [33]. Differential gene expression
was calculated by edgeR v3.24.3 [34] using the model ~0
+group + block, where groupwas a factor with information
about genotype (WT or S22A) and time (d 0, 2 or 6), and
block encoded the two independent Rxra−/- cell lines.
Differential expression was performed using edgeR quasi-
likelihood test on different contrasts. Contrasts were con-
templating differences between genotypes either at different
times, e.g. S22A_D0 – WT_D0, or at different ranges of
time, that is the interaction between genotype and time, e.g.
(SA_D2 – SA_D0) – (WT_D2 – WT_D0). RNA-seq data
was deposited in GEO (GEO: GSE147687).
Statistical analysis
Statistical analyses were performed using GraphPad
Prism 7. Statistical significance was tested using two-
tailed t-test or analysis of variance (ANOVA). Šídák’s,
Dunnett’s or Tukey’s multiple comparison tests were
applied as follow-up tests for two-way ANOVA, as
recommended by Prism 7. Dunnett’s comparison test
was applied after one-way ANOVA. Data were consid-
ered significant if p ≤ 0.05 and are presented as mean ±
standard error (SE) of the mean.
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